ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies
ASCO Updates Guideline On Antiemetics
New Drug Combination Shrinks Kidney Cancers
Docetaxel, Oxaliplatin Active Against Esophageal Cancer
BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery
Communication Is Key To Clinical Trial Enrollment
FDA Approves Treatment For Late-Stage Cervical Cancer
NCI-Approved Clinical Trials
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater